Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Regulation based on ROS homeostasis holds great potential for maintaining physiological homeostasis and treating diseases
The oral small-molecule inhibitor INCB001158 (CB-1158), targeting this axis, has entered first-inhuman phase I studies and has been explored in combination with PD-1 inhibitors, suggesting that relieving substrate depletion-driven immunosuppression is clinically feasible from a safety and pharmacodynamic perspective, although its therapeutic efficacy remains to be fully established (116)
N., Drummond, G
Additionally, it can provide an energy boost and support your immune system throughout the day
DSIP therapy particularly benefits high-performers, athletes, professionals under chronic stress, and anyone prioritizing longevity who recognizes sleep as a foundational health pillar
US$ 28.78
US$ 23.43
US$ 27.40
